More On Tuberculosis

Christopher Fox, Ph.D., Presents a Talk and Poster at Nature Conference’s Bioengineering for Global Health
Stressed stability and protective efficacy of lead lyophilized formulations of ID93+GLA-SE tuberculosis vaccine
Safety and Immunogenicity of the ID93 + GLA-SE Tuberculosis Vaccine in BCG-Vaccinated Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
Tuberculosis kills over a million people a year. New breakthroughs may help humanity fight back.
Local doctor helps develop potential tuberculosis vaccine. Here’s why it is so promising
Thermostable TB Vaccine Found Safe and Immunogenic in Humans

Page [tcb_pagination_current_page] of [tcb_pagination_total_pages]